EP3383371 - Bibliographic data
FORMULATION PHARMACEUTIQUE
| Last update | 15/06/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Avecho Biotechnology Limited Unit A8
2A Westall Road
Clayton, VIC 3168
Australie
|
|---|---|
| (72) Inventors |
Mahmoud EL-TAMIMY 11 Duerdin Street
Clayton, Victoria 3168
Australie
|
| (74) Agent |
Mail recipient Turner, Craig Robert et al AA Thornton IP LLP
8th Floor, 125 Old Broad Street
London EC2N 1AR
Royaume-Uni
|
| (21) Request number | EP16871823.7 |
|---|---|
| (22) Request date | 09/12/2016 |
| (11) Publication number | EP3383371 |
|---|---|
| Publication date | 01/05/2024 |
| (54) Title of the invention | FORMULATION PHARMACEUTIQUE |
|---|---|
| (51) International classification | A61K 9/107, A61K 47/22, A61K 47/26, A61K 47/10, A61P 25/20, A61K 31/05, A61K 31/355, A61P 23/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 2015905089 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 9 -
Amount: 175 € -
Due date 31/12/2024
Surtax: 9 - Amount: 35 € - Due date 01/07/2025 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 01/05/2024 Entrée en période de grâce du brevet d'invention - Legal date 01/01/2025 |